Maternal and Infant Syphilis Prevention Act
Maternal and Infant Syphilis Prevention Act
Plain Language Summary
# Maternal and Infant Syphilis Prevention Act (S 2004) **What It Does** This bill aims to prevent syphilis infections in pregnant women and newborns through expanded federal funding and coordinated public health efforts. While specific details aren't provided in the available information, maternal and infant syphilis prevention bills typically focus on increasing access to prenatal screening, treatment, and education programs. The legislation would likely allocate resources to healthcare providers and public health agencies to identify and treat syphilis in pregnant women, which prevents transmission to babies during pregnancy or birth. **Who It Affects** The bill would primarily affect pregnant women and newborns, particularly in communities with higher rates of untreated syphilis.
It would also impact healthcare providers, clinics, and public health departments that would receive funding and support to implement prevention programs. The bill may also influence pharmaceutical access and testing availability nationwide. **Current Status** As of now, S 2004 is in committee review, meaning it hasn't yet been debated or voted on by the full Senate. The bill was introduced by Senator Martin Heinrich (D-New Mexico) in the 119th Congress.
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.